One day after it started Phase III testing of an antibody cocktail that could be used for COVID-19 patients, Regeneron said it signed a $450 million deal with the U.S. government to make and supply the treatment.
from FOX News https://ift.tt/2VSNvde
v
Tuesday, 7 July 2020
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment